Rupali S. Avasare

3.9k total citations
29 papers, 938 citations indexed

About

Rupali S. Avasare is a scholar working on Nephrology, Molecular Biology and Rheumatology. According to data from OpenAlex, Rupali S. Avasare has authored 29 papers receiving a total of 938 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Nephrology, 12 papers in Molecular Biology and 6 papers in Rheumatology. Recurrent topics in Rupali S. Avasare's work include Renal Diseases and Glomerulopathies (21 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (11 papers) and Chronic Kidney Disease and Diabetes (4 papers). Rupali S. Avasare is often cited by papers focused on Renal Diseases and Glomerulopathies (21 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (11 papers) and Chronic Kidney Disease and Diabetes (4 papers). Rupali S. Avasare collaborates with scholars based in United States, Canada and United Kingdom. Rupali S. Avasare's co-authors include Róbert Langer, Chris Testa, David A. LaVan, Mriganka Sur, Alvin W. Lyckman, Paul George, Gerald B. Appel, Andrew S. Bomback, Pietro A. Canetta and Nicole K. Andeen and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Biomaterials.

In The Last Decade

Rupali S. Avasare

25 papers receiving 917 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rupali S. Avasare United States 12 377 290 260 191 188 29 938
Xiguang Sun China 18 16 0.0× 147 0.5× 311 1.2× 190 1.0× 141 0.8× 30 836
Agustin H. Mohedas United States 6 140 0.4× 29 0.1× 190 0.7× 12 0.1× 286 1.5× 6 833
Delara Motlagh United States 12 48 0.1× 81 0.3× 530 2.0× 17 0.1× 226 1.2× 17 1.2k
Liesbeth Brouwer Netherlands 11 39 0.1× 48 0.2× 240 0.9× 92 0.5× 172 0.9× 15 966
Weiping Ji China 18 10 0.0× 165 0.6× 455 1.8× 42 0.2× 246 1.3× 62 1.2k
Yanchao Chen China 19 23 0.1× 35 0.1× 263 1.0× 66 0.3× 610 3.2× 40 1.5k
Qianqian Li China 12 21 0.1× 69 0.2× 102 0.4× 16 0.1× 107 0.6× 25 459
Xueli Zhao China 12 14 0.0× 53 0.2× 296 1.1× 51 0.3× 287 1.5× 29 871
Justin J. Jeffery United States 17 6 0.0× 130 0.4× 338 1.3× 112 0.6× 236 1.3× 44 1.2k
Tomoko Yamazaki United States 12 18 0.0× 25 0.1× 88 0.3× 198 1.0× 428 2.3× 13 953

Countries citing papers authored by Rupali S. Avasare

Since Specialization
Citations

This map shows the geographic impact of Rupali S. Avasare's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rupali S. Avasare with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rupali S. Avasare more than expected).

Fields of papers citing papers by Rupali S. Avasare

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rupali S. Avasare. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rupali S. Avasare. The network helps show where Rupali S. Avasare may publish in the future.

Co-authorship network of co-authors of Rupali S. Avasare

This figure shows the co-authorship network connecting the top 25 collaborators of Rupali S. Avasare. A scholar is included among the top collaborators of Rupali S. Avasare based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rupali S. Avasare. Rupali S. Avasare is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Andeen, Nicole K., Vanderlene L. Kung, Rupali S. Avasare, et al.. (2025). Questions and Caveats in Antigen-Defined Membranous Nephropathy. Journal of the American Society of Nephrology. 36(8). 1639–1651.
2.
Andeen, Nicole K., Vanderlene L. Kung, Jane Nguyen, et al.. (2025). Bartonella Endocarditis-Associated Glomerulonephritis: A Mimicker of Autoimmunity and Vasculitis. Kidney International Reports. 10(4). 1237–1247.
3.
Avasare, Rupali S., Samantha Clark, Rebecca Spain, et al.. (2024). Characteristics and Outcomes of NELL1 Membranous Nephropathy in Lipoic Acid Users and Nonusers. Kidney International Reports. 9(5). 1379–1386. 8 indexed citations
4.
Andeen, Nicole K., Vanderlene L. Kung, & Rupali S. Avasare. (2024). NELL1 membranous nephropathy: clinical associations provide mechanistic clues. SHILAP Revista de lepidopterología. 4. 1323432–1323432. 3 indexed citations
5.
Kung, Vanderlene L., Rupali S. Avasare, Marcia Friedman, et al.. (2023). Targeted Transcriptional Analysis of IgA Vasculitis, IgA Nephropathy, and IgA-Dominant Infection-Related Glomerulonephritis Reveals Both Distinct and Overlapping Immune Signatures. Kidney360. 4(6). e759–e768. 4 indexed citations
6.
Andeen, Nicole K., et al.. (2022). Fibrillary Glomerulonephritis, DNAJB9, and the Unfolded Protein Response. SHILAP Revista de lepidopterología. 2(4). 164–175. 8 indexed citations
7.
Palmer, Matthew B., Amin Abedini, Shatakshee Chatterjee, et al.. (2021). The Role of Glomerular Epithelial Injury in Kidney Function Decline in Patients With Diabetic Kidney Disease in the TRIDENT Cohort. Kidney International Reports. 6(4). 1066–1080. 21 indexed citations
8.
Avasare, Rupali S., Nicole K. Andeen, Andrea Havasi, & Jonathan J. Hogan. (2021). The Clone Wars: Diagnosing and Treating Dysproteinemic Kidney Disease in the Modern Era. Journal of Clinical Medicine. 10(8). 1633–1633.
9.
Spain, Rebecca, Nicole K. Andeen, Pamela Church Gibson, et al.. (2021). Lipoic acid supplementation associated with neural epidermal growth factor-like 1 (NELL1)–associated membranous nephropathy. Kidney International. 100(6). 1208–1213. 37 indexed citations
10.
Andeen, Nicole K., et al.. (2020). Acute Kidney Injury in a Patient With Monoclonal Gammopathy. American Journal of Kidney Diseases. 76(6). A10–A12. 1 indexed citations
11.
Avasare, Rupali S., Bridget A. Robinson, Jonathan W. Nelson, et al.. (2019). DNAJB9 Is Not Transcriptionally Upregulated in the Glomerulus in Fibrillary Glomerulonephritis. Kidney International Reports. 5(3). 368–372. 7 indexed citations
12.
Avasare, Rupali S., et al.. (2018). Nephrotoxicity of Select Rheumatologic Drugs. Rheumatic Disease Clinics of North America. 44(4). 605–617. 3 indexed citations
13.
Regunathan-Shenk, Renu, Rupali S. Avasare, Wooin Ahn, et al.. (2018). Kidney Transplantation in C3 Glomerulopathy: A Case Series. American Journal of Kidney Diseases. 73(3). 316–323. 55 indexed citations
14.
Avasare, Rupali S., et al.. (2018). Collapsing glomerulopathy in older adults. Modern Pathology. 32(4). 532–538. 7 indexed citations
15.
Bomback, Andrew S., Dominick Santoriello, Rupali S. Avasare, et al.. (2018). C3 glomerulonephritis and dense deposit disease share a similar disease course in a large United States cohort of patients with C3 glomerulopathy. Kidney International. 93(4). 977–985. 113 indexed citations
16.
17.
Avasare, Rupali S., Philip Rosenstiel, Demetra Tsapepas, et al.. (2017). Predicting Post-Transplant Recurrence of IgA Nephropathy: The Importance of Crescents. American Journal of Nephrology. 45(2). 99–106. 26 indexed citations
18.
Avasare, Rupali S. & Jai Radhakrishnan. (2015). Proteinuria as a surrogate marker for renal outcome: are we there yet?. Kidney International. 88(6). 1228–1230. 6 indexed citations
19.
Hogan, Jonathan J., Rupali S. Avasare, & Jai Radhakrishnan. (2014). Is Newer Safer? Adverse Events Associated with First-Line Therapies for ANCA-Associated Vasculitis and Lupus Nephritis. Clinical Journal of the American Society of Nephrology. 9(9). 1657–1667. 21 indexed citations
20.
George, Paul, Alvin W. Lyckman, David A. LaVan, et al.. (2004). Fabrication and biocompatibility of polypyrrole implants suitable for neural prosthetics. Biomaterials. 26(17). 3511–3519. 467 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiguang Sun Breakdown of academic impact, for papers by Agustin H. Mohedas Breakdown of academic impact, for papers by Delara Motlagh Breakdown of academic impact, for papers by Liesbeth Brouwer Breakdown of academic impact, for papers by Weiping Ji Breakdown of academic impact, for papers by Yanchao Chen Breakdown of academic impact, for papers by Qianqian Li Breakdown of academic impact, for papers by Xueli Zhao Breakdown of academic impact, for papers by Justin J. Jeffery Breakdown of academic impact, for papers by Tomoko Yamazaki
Rankless by CCL
2026